vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and WARRIOR MET COAL, INC. (HCC). Click either name above to swap in a different company.
WARRIOR MET COAL, INC. is the larger business by last-quarter revenue ($384.0M vs $196.0M, roughly 2.0× Axsome Therapeutics, Inc.). WARRIOR MET COAL, INC. runs the higher net margin — 6.0% vs -14.6%, a 20.6% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 29.1%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs -12.7%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Warrior Met Coal, Inc. (ticker HCC) is a U.S.-headquartered mining enterprise that produces and distributes high-grade metallurgical coal, a key raw material for steel production. It serves steel manufacturers and industrial clients across core markets including North America, Europe, and Asia.
AXSM vs HCC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $384.0M |
| Net Profit | $-28.6M | $23.0M |
| Gross Margin | — | 29.5% |
| Operating Margin | -13.8% | 9.0% |
| Net Margin | -14.6% | 6.0% |
| Revenue YoY | 65.0% | 29.1% |
| Net Profit YoY | 61.9% | 1919.5% |
| EPS (diluted) | $-0.55 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $384.0M | ||
| Q3 25 | $171.0M | $328.6M | ||
| Q2 25 | $150.0M | $297.5M | ||
| Q1 25 | $121.5M | $299.9M | ||
| Q4 24 | $118.8M | $297.5M | ||
| Q3 24 | $104.8M | $327.7M | ||
| Q2 24 | $87.2M | $396.5M | ||
| Q1 24 | $75.0M | $503.5M |
| Q4 25 | $-28.6M | $23.0M | ||
| Q3 25 | $-47.2M | $36.6M | ||
| Q2 25 | $-48.0M | $5.6M | ||
| Q1 25 | $-59.4M | $-8.2M | ||
| Q4 24 | $-74.9M | $1.1M | ||
| Q3 24 | $-64.6M | $41.8M | ||
| Q2 24 | $-79.3M | $70.7M | ||
| Q1 24 | $-68.4M | $137.0M |
| Q4 25 | — | 29.5% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 23.9% | ||
| Q1 25 | — | 18.1% | ||
| Q4 24 | — | 23.1% | ||
| Q3 24 | — | 29.3% | ||
| Q2 24 | — | 34.1% | ||
| Q1 24 | — | 43.3% |
| Q4 25 | -13.8% | 9.0% | ||
| Q3 25 | -27.0% | 6.3% | ||
| Q2 25 | -24.5% | 2.6% | ||
| Q1 25 | -46.9% | -5.8% | ||
| Q4 24 | -61.1% | -1.4% | ||
| Q3 24 | -59.8% | 11.9% | ||
| Q2 24 | -89.5% | 17.9% | ||
| Q1 24 | -89.7% | 29.6% |
| Q4 25 | -14.6% | 6.0% | ||
| Q3 25 | -27.6% | 11.1% | ||
| Q2 25 | -32.0% | 1.9% | ||
| Q1 25 | -48.9% | -2.7% | ||
| Q4 24 | -63.1% | 0.4% | ||
| Q3 24 | -61.7% | 12.7% | ||
| Q2 24 | -91.0% | 17.8% | ||
| Q1 24 | -91.1% | 27.2% |
| Q4 25 | $-0.55 | $0.43 | ||
| Q3 25 | $-0.94 | $0.70 | ||
| Q2 25 | $-0.97 | $0.11 | ||
| Q1 25 | $-1.22 | $-0.16 | ||
| Q4 24 | $-1.54 | $0.02 | ||
| Q3 24 | $-1.34 | $0.80 | ||
| Q2 24 | $-1.67 | $1.35 | ||
| Q1 24 | $-1.44 | $2.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $300.0M |
| Total DebtLower is stronger | — | $154.3M |
| Stockholders' EquityBook value | $88.3M | $2.1B |
| Total Assets | $689.8M | $2.8B |
| Debt / EquityLower = less leverage | — | 0.07× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $300.0M | ||
| Q3 25 | $325.3M | $336.3M | ||
| Q2 25 | $303.0M | $383.3M | ||
| Q1 25 | $300.9M | $454.9M | ||
| Q4 24 | $315.4M | $491.5M | ||
| Q3 24 | $327.3M | $583.2M | ||
| Q2 24 | $315.7M | $709.0M | ||
| Q1 24 | $331.4M | $693.9M |
| Q4 25 | — | $154.3M | ||
| Q3 25 | — | $154.1M | ||
| Q2 25 | — | $153.9M | ||
| Q1 25 | — | $153.8M | ||
| Q4 24 | — | $153.6M | ||
| Q3 24 | — | $153.5M | ||
| Q2 24 | — | $153.3M | ||
| Q1 24 | — | $153.2M |
| Q4 25 | $88.3M | $2.1B | ||
| Q3 25 | $73.7M | $2.1B | ||
| Q2 25 | $73.1M | $2.1B | ||
| Q1 25 | $53.2M | $2.1B | ||
| Q4 24 | $57.0M | $2.1B | ||
| Q3 24 | $92.9M | $2.1B | ||
| Q2 24 | $102.9M | $2.0B | ||
| Q1 24 | $144.0M | $2.0B |
| Q4 25 | $689.8M | $2.8B | ||
| Q3 25 | $669.3M | $2.7B | ||
| Q2 25 | $639.8M | $2.6B | ||
| Q1 25 | $596.7M | $2.6B | ||
| Q4 24 | $568.5M | $2.6B | ||
| Q3 24 | $561.5M | $2.6B | ||
| Q2 24 | $548.2M | $2.6B | ||
| Q1 24 | $545.7M | $2.5B |
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.07× | ||
| Q3 24 | — | 0.07× | ||
| Q2 24 | — | 0.07× | ||
| Q1 24 | — | 0.08× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $76.1M |
| Free Cash FlowOCF − Capex | $-18.7M | — |
| FCF MarginFCF / Revenue | -9.6% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 3.31× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $76.1M | ||
| Q3 25 | $1.0M | $104.7M | ||
| Q2 25 | $-32.4M | $37.5M | ||
| Q1 25 | $-43.4M | $10.9M | ||
| Q4 24 | $-26.2M | $54.2M | ||
| Q3 24 | $-18.6M | $62.2M | ||
| Q2 24 | $-30.1M | $147.0M | ||
| Q1 24 | $-53.5M | $104.1M |
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | — | ||
| Q2 25 | $-32.4M | — | ||
| Q1 25 | $-43.7M | — | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.7M | — | ||
| Q2 24 | $-30.2M | — | ||
| Q1 24 | $-53.6M | — |
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | -21.6% | — | ||
| Q1 25 | -36.0% | — | ||
| Q4 24 | -22.1% | — | ||
| Q3 24 | -17.9% | — | ||
| Q2 24 | -34.6% | — | ||
| Q1 24 | -71.4% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | 3.31× | ||
| Q3 25 | — | 2.86× | ||
| Q2 25 | — | 6.70× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 47.68× | ||
| Q3 24 | — | 1.49× | ||
| Q2 24 | — | 2.08× | ||
| Q1 24 | — | 0.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
HCC
| Mining Segment | $373.6M | 97% |
| Other | $10.4M | 3% |
